by
Gus Iversen, Editor in Chief | May 04, 2026
BD has introduced a new central venous catheter (CVC) insertion system designed to consolidate multiple steps of the procedure into a single device, as the company expands its presence in the acute vascular access market.
The Franklin Lakes, New Jersey-based company said its CentroVena One system combines the introducer needle, syringe, guidewire and catheter into one platform. Central line placement is performed millions of times annually in the U.S., but typically involves multiple component exchanges that can increase the risk of contamination and procedural complications.
“CentroVena One represents the most meaningful advancement in central line insertion since the technique was first introduced nearly seven decades ago,” said Ron Silverman, executive vice president and chief medical officer at BD.
Ad Statistics
Times Displayed: 101
Times Visited: 0 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money.
According to the company, the system is intended to reduce procedural complexity by lowering the number of steps involved and limiting touchpoints during insertion. BD cited internal data indicating a reduction in procedure steps and insertion time compared with traditional CVC kits, based on a simulation study published in the
Journal of Emergency Medicine in December 2025.
The device incorporates several design features aimed at reducing complications associated with central line placement, including a preloaded guidewire, a self-dilating catheter tip and a passive needle safety mechanism. It also uses a closed insertion approach intended to reduce risks such as air embolism, blood exposure and blood loss.
UNC Health Blue Ridge has begun evaluating the system in clinical settings. “What stands out in our early experience with CentroVena One is its intentional design around real-world clinical challenges; streamlining catheter placement while reducing opportunities for error,” said Anthony Frank, M.D., MBA, FACEP, chief medical officer and senior vice president of medical affairs at the health system.
The device received FDA 510(k) clearance and was accepted into the agency’s Safer Technologies Program, which highlights devices expected to improve safety compared with existing options.
